Results 31 to 40 of about 6,539 (194)
Ожирение и метаболизм, 2015 Objective: To evaluate the effectiveness and safety of cabergoline drug Bergolak («Veropharm», Russia) in the treatment of patients with prolactin-secreting tumors.Materials and methods: The study included 14 patients (14 women, mean age 46±12) diagnosed
Galina Afanas'evna Melnichenko +3 more
doaj +1 more source
Cabergoline treatment in acromegaly: pros [PDF]
, 2014 Cabergoline is an ergot-derived dopamine D2 receptor agonist which may be effective for the medical management of acromegaly. Its efficacy in reducing growth hormone and IGF-I levels, as well as its antiproliferative and pro-apoptotic effects on ...
Ramos-Levi, A +3 more
core +1 more source
Saudi Pharmaceutical Journal, 2023 Background: There is evidence that vaginal cabergoline can help to prevent ovarian hyperstimulation syndrome. Therefore, the vaginal suppository may be a good choice because it can be administered directly into the vagina and has no adverse effects on ...
Pouria Rahmanian-Devin +3 more
doaj +1 more source
Cabergoline for preventing ovarian hyperstimulation syndrome [PDF]
, 2012 Background Ovarian hyperstimulation syndrome (OHSS) is a complication resulting from administration of human chorionic gonadotrophin (hCG) in assisted reproduction technology (ART) treatment.
Huilin Tang +11 more
core +1 more source
De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
Clinical Medicine Insights: Case Reports, 2023 Dopamine agonists are the first-line treatment of prolactinomas. The risk of developing de novo psychiatric symptoms during dopamine agonist therapy is low.
Chayma Belhadj Slimane +4 more
doaj +1 more source
Effectiveness of Cabergoline therapy in hyperprolactinemic infertility [PDF]
, 2019 Background: Hyperprolactinemia may be associated with ovulatory dysfunction and resultant subfertility. Hyperprolactinemia affects the pulsatile release of GnRH, which in turn impairs the secretion of FSH and LH. It may also affect the endocrine activity
Pitale, Devdatt Laxman
core +2 more sources
Middle East Fertility Society Journal, 2011 Background: Prophylactic use of dopamine agonist has been associated with a decrease in the severity of ovarian hyperstimulation syndrome (OHSS). Objective: To compare cabergoline with cabergoline plus I.V albumin or I.V albumin alone in prevention of ...
Badeea S. Soliman
doaj +1 more source
Cabergoline: an effective treatment for conception in prolactinoma [PDF]
, 2022 Background and objective: Prolactinoma is an uncommon cause of amenorrhea and subfertility in females. When diagnosed, symptoms resolve with medical treatment in 90% of the cases.
Zahra Safdar +3 more
core +1 more source
Novel Medicine for Endometriosis and Its Therapeutic Effect in a Mouse Model
Biomedicines, 2020 Current therapeutic medicines for endometriosis cannot be administered during assisted reproductive technology (ART) because they have bad effects during pregnancy.
Young Sang Kim +5 more
doaj +1 more source